First-line combination chemotherapy with mitoxantrone, methotrexate, vincristine and carboplatin (MIMOC) in advanced breast cancer.

D Bafaloukos; G Samonis; A Klinaki; D Daliani; N Karvounis; C Bacoyiannis; A Karabelis; N Milonakis; P Kosmidis

doi:10.1016/s0959-8049(05)80422-8

First-line combination chemotherapy with mitoxantrone, methotrexate, vincristine and carboplatin (MIMOC) in advanced breast cancer.

Identifier:nobleid.org/w1/20260515/7325F024

Type:Journal Article

0 views

Support unavailableClaim Your Authorship

View Original Paper Source

Embeddable Badge

[![NobleID](https://www.nobleid.org/api/badge/7325F024.svg?ark=w1%2F20260515%2F7325F024)](https://nobleid.org/work/w1/20260515/7325F024)

ARK Inflections

Metadata Policy

Metadata Formats

Bibliometric Analysis

Impact metrics, research fronts, co-authorship networks →

Authors & Claims

Paper Authors

Claim authorship of this work

First-line combination chemotherapy with mitoxantrone, methotrexate, vincristine and carboplatin (MIMOC) in advanced breast cancer.

Identifier:nobleid.org/w1/20260515/7325F024

Type:Journal Article

0 views

Support unavailableClaim Your Authorship

View Original Paper Source

Embeddable Badge

[![NobleID](https://www.nobleid.org/api/badge/7325F024.svg?ark=w1%2F20260515%2F7325F024)](https://nobleid.org/work/w1/20260515/7325F024)

ARK Inflections

Metadata Policy

Metadata Formats

Bibliometric Analysis

Impact metrics, research fronts, co-authorship networks →

Authors & Claims

Paper Authors

Claim authorship of this work